Vintura adds two members to leadership team in Munich

Vintura has welcomed two senior members to its team in Germany, with Jan-Philipp Beck arriving as a partner and Ann-Sophie Kuschel as a principal consultant.

With a team of around 80 staff, Vintura is a strategy and management consultancy company specialised in two industry verticals: life sciences and healthcare. The firm operates with offices in the Netherlands, the United Kingdom, France and Germany.

Strengthening the latter operation, which operates out of Munich, Jan-Philipp Beck and Ann-Sophie Kuschel bring more than three decades of combined expertise to the consulting firm. Beck arrived late last year, while Kuschel commenced her role early this year.

In the role of partner, Beck has been tasked with spearheading the firm’s expansion in the German market. His core expertise lies in the healthcare sector: “I help our clients with the development and execution of strategies aimed at achieving higher quality, more effective, efficient and patient-centric care. Throughout my career I have helped public and private organisations with enabling innovation pathways – including digital health,” he said.

Prior to joining Vintura, Beck was chief executive officer of EIT Health, a Munich-based pan-European health innovation network with more than 150 partner organisations across Europe. Earlier, he held roles at Big Four firm, serving EY and Deloitte in their respective consulting arms.

During his career Beck has built a wide (international) network of healthcare stakeholders including public organisations, private players, healthcare providers, industry bodies, start-ups and investors.

Kuschel meanwhile joined Vintura from IQVIA, where she spent seven years in its advisory division, most recently as a project manager specialised in market access and healthcare technology assessment.

“My years of experience as a market access expert have helped me understand how important it is to involve all stakeholders in the process at an early stage to ensure, for example, that clinical trials are suitable not only for approval but also for market access. At Vintura, I will bring this knowledge to our clients seeking to launch new products in the healthcare market,” she said.

Earlier in her career, Kuschel worked as a pharmacist, after completing her PhD in Pharmacy at the University of Tübingen.

Commenting on the appointments, Bas Amesz, partner at Vintura in the Netherlands, said: “We are glad that Jan-Philipp and Ann-Sophie have joined the Vintura team. They both reflect our drive to create impact in healthcare and are passionate about transforming the sector through collaboration, partnerships and innovation. With the on board, our Munich offices will continue its expansion.”

In May last year, Vintura joined forces with Cepton, a likeminded consultancy in France. Both consultancies operate under their own brand, but increasingly work together on joint client engagements and thought leadership. The two companies are part of AmerisourceBergen Group, a worldwide provider of solutions for the pharma, biotech and medtech industry.